相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Rat Model of Progressive Nigral Neurodegeneration Induced by the Parkinson's Disease-Associated G2019S Mutation in LRRK2
Julien Dusonchet et al.
JOURNAL OF NEUROSCIENCE (2011)
Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice
B. Winner et al.
NEUROBIOLOGY OF DISEASE (2011)
Genome-Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease
Todd L. Edwards et al.
ANNALS OF HUMAN GENETICS (2010)
Nonmotor Symptoms in Genetic Parkinson Disease
Meike Kasten et al.
ARCHIVES OF NEUROLOGY (2010)
LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
Agnes Gardet et al.
JOURNAL OF IMMUNOLOGY (2010)
LRRK2 Kinase Regulates Synaptic Morphology through Distinct Substrates at the Presynaptic and Postsynaptic Compartments of the Drosophila Neuromuscular Junction
Seongsoo Lee et al.
JOURNAL OF NEUROSCIENCE (2010)
Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S
Xianting Li et al.
JOURNAL OF NEUROSCIENCE (2010)
Penetrance in Parkinson's Disease Related to the LRRK2 R1441G Mutation in the Basque Country (Spain)
Javier Ruiz-Martinez et al.
MOVEMENT DISORDERS (2010)
Clinical Expression of LRRK2 G2019S Mutations in the Elderly
Marta San Luciano et al.
MOVEMENT DISORDERS (2010)
LRRK2 G2019S Mutations are Associated with an Increased Cancer Risk in Parkinson Disease
Rachel Saunders-Pullman et al.
MOVEMENT DISORDERS (2010)
Dopamine Turnover Increases in Asymptomatic LRRK2 Mutations Carriers
Vesna Sossi et al.
MOVEMENT DISORDERS (2010)
Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression
Stephan Gehrke et al.
NATURE (2010)
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Byoung Dae Lee et al.
NATURE MEDICINE (2010)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease
Chen Yao et al.
NEUROBIOLOGY OF DISEASE (2010)
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
H. L. Melrose et al.
NEUROBIOLOGY OF DISEASE (2010)
Genetic Animal Models of Parkinson's Disease
Ted M. Dawson et al.
NEURON (2010)
A comparative study of Lrrk2 function in primary neuronal cultures
Justus C. Daechsel et al.
PARKINSONISM & RELATED DISORDERS (2010)
Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice
Youren Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
GTPase Activity Plays a Key Role in the Pathobiology of LRRK2
Yulan Xiong et al.
PLOS GENETICS (2010)
Mouse models of Huntington disease: variations on a theme
Dagmar E. Ehrnhoefer et al.
DISEASE MODELS & MECHANISMS (2009)
LRRK2 in Parkinson's disease: in vivo models and approaches for understanding pathogenic roles
Zhenyu Yue
FEBS JOURNAL (2009)
Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability - a point of convergence in Parkinsonian neurodegeneration?
Frank Gillardon
JOURNAL OF NEUROCHEMISTRY (2009)
Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal Morphogenesis
Loukia Parisiadou et al.
JOURNAL OF NEUROSCIENCE (2009)
Unexpected Lack of Hypersensitivity in LRRK2 Knock-Out Mice to MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine)
Eva Andres-Mateos et al.
JOURNAL OF NEUROSCIENCE (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li et al.
NATURE NEUROSCIENCE (2009)
Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synuclein
Xian Lin et al.
NEURON (2009)
Genomewide Association Study of Leprosy
Fu-Ren Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice
Youren Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
Yuzuru Imai et al.
EMBO JOURNAL (2008)
LRRK2 regulates synaptic vesicle endocytosis
Narae Shin et al.
EXPERIMENTAL CELL RESEARCH (2008)
Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2
Michael J. Devine et al.
FEBS JOURNAL (2008)
Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice
Michelle Gray et al.
JOURNAL OF NEUROSCIENCE (2008)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Glial reactions in Parkinson's disease
Patrick L. McGeer et al.
MOVEMENT DISORDERS (2008)
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
Jeffrey C. Barrett et al.
NATURE GENETICS (2008)
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease
K. Haugarvoll et al.
NEUROLOGY (2008)
Hyposmia in G2019S LRRK2-related parkinsonism - Clinical and pathologic data
L. Silveira-Moriyama et al.
NEUROLOGY (2008)
Progression of dopaminergic dysfunction in a LRRK2 kindred A multitracer PET study
R. Nandhagopal et al.
NEUROLOGY (2008)
PROGRESSIVE SYNAPTIC PATHOLOGY OF MOTOR CORTICAL NEURONS IN A BAC TRANSGENIC MOUSE MODEL OF HUNTINGTON'S DISEASE
J. Spampanato et al.
NEUROSCIENCE (2008)
A Drosophila model for LRRK2-linked parkinsonism
Zhaohui Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation
D. S. Goldstein et al.
NEUROLOGY (2007)
The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity
Luxuan Guo et al.
EXPERIMENTAL CELL RESEARCH (2007)
Evaluation of LRRK2 G2019S penetrance -: Relevance for genetic counseling in Parkinson disease
S. Goldwurm et al.
NEUROLOGY (2007)
LRK-1, a C-elegans PARK8-Related kinase, regulates axonal-dendritic polarity of SV proteins
Aisa Sakaguchi-Nakashima et al.
CURRENT BIOLOGY (2007)
GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease
Genta Ito et al.
BIOCHEMISTRY (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease
L. N. Clark et al.
NEUROLOGY (2006)
The familial parkinsonism gene LRRK2 regulates neurite process morphology
David MacLeod et al.
NEURON (2006)
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
Saskia Biskup et al.
ANNALS OF NEUROLOGY (2006)
Parkinsonism, Lrrk2 G2019S, and tau neuropathology
A. Rajput et al.
NEUROLOGY (2006)
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W. Smith et al.
NATURE NEUROSCIENCE (2006)
Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation
Ioannis U. Isaias et al.
MOVEMENT DISORDERS (2006)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
LRRK2 expression linked to dopamine-innervated areas
D Galter et al.
ANNALS OF NEUROLOGY (2006)
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews
LJ Ozelius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
CJ Gloeckner et al.
HUMAN MOLECULAR GENETICS (2006)
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration
WW Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation
JR Adams et al.
BRAIN (2005)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology
ZK Wszolek et al.
NEUROLOGY (2004)
Bac to the future: The use of bac transgenic mice for neuroscience research
N Heintz
NATURE REVIEWS NEUROSCIENCE (2001)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)
分享论文
